Orbis Research’s newly added “Endometriosis – Market Insights, Epidemiology and Market Forecast-2023” Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
“Endometriosis – Market Insights, Epidemiology and Market Forecast-2023” Report provides an overview of the disease and global market size of the Endometriosis for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan. It also includes global historical and forecasted epidemiological data for the prevalent, diagnosed and treatable cases of Endometriosis from 2013-2023.
Endometriosis is the abnormal growth of endometrial tissue similar to that which lines the interior of the uterus, but in a location outside of the uterus. It is usually developed in Peritoneum, fallopian tubes, Ovaries, Cul-de-sac (the space behind the uterus), Outer surfaces of the uterus, bladder, ureters, intestines, and rectum. Worldwide in 2012, 527,600 women were diagnosed with Endometriosis.
The mortality rate was 1.7 to 2.4 per 100,000 women. In the United States, as with other developed countries Endometriosis was the most common gynecologic malignancy, with over 60,000 new cases and over 10,000 deaths from the disease in each year.
- Elagolix: AbbVie Inc
- Femitra: EndoCeutics Inc
- BAY 86-5300: Bayer HealthCare Pharmaceuticals
Request Sample Report at: http://www.orbisresearch.com/contacts/request-sample/209381
Lupron, developed by Abbvie is the top selling drug of Endometriosis contributing to majority of the market size. Other top players include Visanne/Dienogest (Bayer Healthcare), Zoladex (AstraZeneca), Synarel (Pfizer) and Depo-SubQ Provera (Pfizer). According to DelveInsight, the worldwide Endometriosis market is estimated to be USD 1.91 Billion by 2023 at a CAGR of 1.33%.
- Depo-SubQ Provera 104
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Enquire more about the Report Details at: http://www.orbisresearch.com/contacts/enquiry-before-buying/209381
- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details.
- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023.
- It also provides Market size of Endometriosis for United States, EU5 and Japan from 2013 and forecasted Market size to 2023.
Points Covered in Report:
Endometriosis Market Overview at a Glance
Global Market Size of Endometriosis in 2015
Global Market Size of Endometriosis in 2023
Epidemiology of Endometriosis in 7MM
… and Continued
Orbis Research is a single point aid for all your Market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required Market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com